Acacia Pharma Overview

  • Founded
  • 2007
Founded
  • Status
  • Public
  • Employees
  • 72
Employees
  • Stock Symbol
  • ACPH
Stock Symbol
  • Share Price
  • $2.37
  • (As of Monday Closing)

Acacia Pharma General Information

Description

Acacia Pharma Group PLC is a biopharmaceutical company that focuses on developing and commercializing novel products to improve the care of patients undergoing medical treatments such as surgery, invasive procedures, or chemotherapy. Its product portfolio includes BARHEMSYS, BYFAVO, and APD403.

Contact Information

Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Stock Exchange
BRU
Primary Office
  • The Officers' Mess
  • Royston Road
  • Cambridge CB22 4QH
  • England, United Kingdom
+44 01223 000000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Acacia Pharma Stock Performance

(As of Monday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.37 $2.42 $2.11 - $4.20 $237M 100M 180K -$0.46

Acacia Pharma Financials Summary

In Thousands,
USD
TTM 31-Dec-2020 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 275,006 275,006 116,961 43,684
Revenue 211 211 0
EBITDA (28,797) (28,797) (22,356) (19,054)
Net Income (33,478) (33,478) (22,839) (20,692)
Total Assets 102,835 102,835 18,669 38,714
Total Debt 36,692 36,692 10,154 9,317
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Acacia Pharma Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Acacia Pharma‘s full profile, request access.

Request a free trial

Acacia Pharma Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore Acacia Pharma‘s full profile, request access.

Request a free trial

Acacia Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Acacia Pharma Group PLC is a biopharmaceutical company that focuses on developing and commercializing novel products to
Pharmaceuticals
Cambridge, United Kingdom
72 As of 2020
00000
000000000 00000

00000 00

im ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequa
000000000000000
Morrisville, NC
00 As of 0000
000.00
000000000 000.00

00000000

uis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur
000000000000000
Basel, Switzerland
000000 As of 0000
000000000000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Acacia Pharma Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Tenax Therapeutics Formerly Angel backed Morrisville, NC 00 000.00 000000000 000.00
00000000 Corporation Basel, Switzerland 000000 000000000000
00000 000000000000 Formerly VC-backed Palatine, IL 00 00000 000000000 - 00000
000000000000000000 Corporation Toronto, Canada 00 000.00 000000000 000.00
00 000000000000 Formerly VC-backed Durham, NC 000 00000 000000 - 000 00000
You’re viewing 5 of 11 competitors. Get the full list »

Acacia Pharma Executive Team (9)

Name Title Board Seat Contact Info
Mike Bolinder Chief Executive Officer & Board Member
Gary Gemignani Chief Financial Officer
Robert Gristwood Chief Scientific Officer & Co-Founder
Debra Hussain Chief Commercial Officer
Ian Walker Ph.D Head of Project Leadership
You’re viewing 5 of 9 executive team members. Get the full list »

Acacia Pharma Board Members (12)

Name Representing Role Since
Edward Borkowski Self Board Member 000 0000
John Brown Ph.D Self Board Member 000 0000
Mike Bolinder Acacia Pharma Chief Executive Officer & Board Member 000 0000
Pieter Van der Meer Gilde Healthcare Partners Board Member 000 0000
You’re viewing 4 of 12 board members. Get the full list »

Acacia Pharma Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Acacia Pharma Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Acacia Pharma‘s full profile, request access.

Request a free trial